The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
The second-generation antipsychotic olanzapine is effective in reducing psychotic symptoms but can cause extreme weight gain in human patients. We investigated the role of the gut microbiota in this adverse drug effect using a mouse model. First, we used germ-free C57BL/6J mice to demonstrate that gut bacteria are necessary and sufficient for weight gain caused by oral delivery of olanzapine. Second, we surveyed fecal microbiota before, during, and after treatment and found that olanzapine potentiated a shift towards an "obesogenic" bacterial profile. Finally, we demonstrated that olanzapine has antimicrobial activity in vitro against resident enteric bacterial strains. These results collectively provide strong evidence for a mechanism underlying olanzapine-induced weight gain in mouse and a hypothesis for clinical translation in human patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Effect of high-fat diet (HFD) and olanzapine (OLZ) treatment on diversity of gut microbiota during crossover study. (A) Within-subject (α) diversity, quantified by Fisher's α [45]; larger values indicate greater diversity (n = 95 samples = 4 time points ×24 subjects – 1 failed sample). Panels are split by study arm (see Error! Reference source not found.) and points are colored according to diet and treatment status: on regular chow prior to initiation of HFD (regular), during treatment with placebo (HFD-placebo) or during treatment with OLZ (HFD-OLZ). Each point represents a single individual and bars indicate 95% confidence intervals about the point estimates; observations on the same subject are connected by a grey line. (B) Between-subjects (β) diversity (n = 95 samples = 4 time points ×24 subjects – 1 failed sample). Pairwise distances between samples were calculated using weighted UniFrac and visualized using non-metric multidimensional scaling along two axes, which together explain 98% of between-subjects variance. Observations on the same subject are connected by a grey line.](https://figures.cochat.ai/paper-figures/a936ae05344f4303a8dbe754682036f6/the-antipsychotic-olanzapine-interacts-with-the-gut-microbiome-to-cause-weight-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Olanzapine administration decreased overall microbial diversity, lowered abundance of Bacteroidia, and increased abundances of Erysipelotrichia, Actinobacteria, and Gammaproteobacteria.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [188]
In the citing paper
“a lack of significant increase of the body weight in olanzapine-treated GF mice and a rapid weight gain upon microbial colonization in this study indicate that the olanzapine-induced weight gain was dependent on the presence of gut microbiota [188].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [188]
In the citing paper
“olanzapine, which induces alterations in gut microbiome composition in rodents linked to the weight gain and other metabolic side effects that are associated with its use”
From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Morgan et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“0 package [38].”
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885 · cited 1×
“OTUs were assigned a taxonomic identity with the RDP classifier [37] trained on the most recent release (4 February 2011) of the Los Alamos National Laboratory’s GreenGenes taxonomic reference (gg_97_otus_4feb2011), using the scripts in the QIIME v1.”
MethodA new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828 · cited 2×
“Between-group differences in overall microbiota composition were assessed by PERMANOVA [42] as implemented in the R package vegan (http://vegan.r-forge.r-project.org), and visualized using nonmetric multidimensional scaling as implemented in the R package MASS [43].”
MethodAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Recent studies in animal models and humans have demonstrated a causal role for the gut microbiome in obesity [19–24], which is mediated by complex interactions with host environment [25, 26], diet [21, 27] and genetics [25, 28].”
BackgroundA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“Bacterial concentrations can be as high as 10(11) cells/mL in the distal gut, encompassing a gene repertoire 150 times larger than that of the human host [15] with broad-ranging metabolic capacity [16, 17].”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“The specific alterations in gut community composition that we attribute to olanzapine are similar to those attributed to high-fat diet [19, 21, 22, 30, 31].”
BackgroundUniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227 · cited 8×
“In the weighted UniFrac analysis (Fig.”
MethodInfluentialEffectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · cited 1×
“Since their introduction in the 1990s, olanzapine and other atypical antipsychotics have come into widespread clinical use because they are efficacious and usually lack the extrapyramidal adverse drug reactions associated with older, ‘‘typical’’ antipsychotics like haloperidol [1, 2].”
BackgroundFastTree: Computing Large Minimum Evolution Trees with Profiles instead of a Distance Matrix
Price, M. N., Dehal, P. S., & Arkin, A. P. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp077 · Cited by 5,602 · cited 1×
“Consensus sequences for the OTUs were aligned using PyNAST [39] (via QIIME) guided by the aforementioned GreenGenes reference alignment, and a corresponding phylogeny inferred using FastTree [40] (via QIIME).”
MethodGut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 2×
“This pattern has previously been associated with obesity in mouse and human [19, 24].”
Fisher, R. A., Corbet, A. S., & Williams, C. B. (1943) · The Journal of Animal Ecology · doi:10.2307/1411 · Cited by 3,487 · cited 2×
“The switch to high-fat diet was associated with a modest increase in within-sample microbial diversity (a-diversity) after adjusting for temporal and co-housing effects (Fisher’s a [45], 95% CI 23.”
BackgroundPyNAST: a flexible tool for aligning sequences to a template alignment
Caporaso, J. G., Bittinger, K., Bushman, F. D., DeSantis, T. Z., Andersen, G. L., & Knight, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp636 · Cited by 3,396 · cited 1×
“Consensus sequences for the OTUs were aligned using PyNAST [39] (via QIIME) guided by the aforementioned GreenGenes reference alignment, and a corresponding phylogeny inferred using FastTree [40] (via QIIME).”
MethodThe Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058 · cited 2×
“The specific alterations in gut community composition that we attribute to olanzapine are similar to those attributed to high-fat diet [19, 21, 22, 30, 31].”
BackgroundMechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435 · cited 1×
“Both Erysipelotrichi and Gammaproteobacteria have been associated with non-alcoholic fatty liver disease independently of weight gain in human [51, 52] and mouse [53].”
BackgroundKrämer, W. (2003) · Computational Statistics & Data Analysis · Cited by 1,858
Antibiotics in early life alter the murine colonic microbiome and adiposity
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. (2012) · Nature · doi:10.1038/nature11400 · Cited by 1,613 · cited 1×
“Such treatments have been shown to shape the composition and the metabolic capacity of the gut microbiota in mice, resulting in long-term changes in energy balance [23].”
BackgroundTiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354 · cited 1×
“Cardiovascular disease is a leading cause of death in schizophrenia [3, 9]: tobacco use, poor diet, and socioeconomic disparities conspire to create a profoundly unfavorable cardiovascular risk profile that is compounded by weight gain and the metabolic side effects of antipsychotic drugs.”
BackgroundPrinciples and clinical implications of the brain-gut-enteric microbiota axis
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342 · cited 1×
“Complex bidirectional interactions occur between the brain, endocrine system, enteric nervous system, gut epithelium and microbiota in both rodents and humans [57], and olanzapine may perturb this ‘‘brain-gut-enteric microbiota’’ axis.”
BackgroundBenson, A. K., Kelly, S. A., Legge, R., Ma, F., Low, S. J., Kim, J., Zhang, M., Oh, P. L., Nehrenberg, D., Hua, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007028107 · Cited by 1,314 · cited 2×
“The composition of the gut microbiota has been shown to be heritable and genetically complex [28].”
BackgroundCorrell, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050 · cited 1×
“However, atypical antipsychotics can induce dramatic weight gain: 11–17 kg in a systematic review of treatment-naïve adults [3] and 7–9 kg in adolescents over short-term treatment [4].”
BackgroundPractical innovations for high-throughput amplicon sequencing
Lundberg, D. S., Yourstone, S., Mieczkowski, P., Jones, C. D., & Dangl, J. L. (2013) · Nature Methods · doi:10.1038/nmeth.2634 · Cited by 1,009 · cited 1×
“Hypervariable region 4 (V4) of the 16S ribosomal RNA subunit gene was amplified by the molecule-tagged PCR method [36] Briefly, this technique adds a unique oligonucleotide sequence (the ‘‘molecular tag’’) to each template molecule in the first round of amplification so that PCR artifacts are readily identified and co…”
MethodGenomic variation landscape of the human gut microbiome
Schloissnig, S., Arumugam, M., Sunagawa, S., Mitreva, M., Tap, J., Zhu, A., Waller, A., Mende, D. R., Kultima, J. R., Martin, J., et al. (2013) · Nature · doi:10.1038/nature11711 · Cited by 907 · cited 1×
“Recent studies in animal models and humans have demonstrated a causal role for the gut microbiome in obesity [19–24], which is mediated by complex interactions with host environment [25, 26], diet [21, 27] and genetics [25, 28].”
BackgroundXenobiotics shape the physiology and gene expression of the active human gut microbiome
Maurice, C. F., Haiser, H. J., & Turnbaugh, P. J. (2013) · Cell · doi:10.1016/j.cell.2012.10.052 · Cited by 811 · cited 1×
“Bacterial concentrations can be as high as 10(11) cells/mL in the distal gut, encompassing a gene repertoire 150 times larger than that of the human host [15] with broad-ranging metabolic capacity [16, 17].”
BackgroundThe human gut microbiome: ecology and recent evolutionary changes
Walter, J., & Ley, R. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102830 · Cited by 720 · cited 1×
“Bacterial concentrations can be as high as 10(11) cells/mL in the distal gut, encompassing a gene repertoire 150 times larger than that of the human host [15] with broad-ranging metabolic capacity [16, 17].”
BackgroundRaman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672 · cited 1×
“Both Erysipelotrichi and Gammaproteobacteria have been associated with non-alcoholic fatty liver disease independently of weight gain in human [51, 52] and mouse [53].”
BackgroundMedical Comorbidity in Schizophrenia
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.413 · Cited by 624
Spencer, M. D., Hamp, T. J., Reid, R. W., Fischer, L. M., Zeisel, S. H., & Fodor, A. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.049 · Cited by 593 · cited 1×
“Both Erysipelotrichi and Gammaproteobacteria have been associated with non-alcoholic fatty liver disease independently of weight gain in human [51, 52] and mouse [53].”
BackgroundOlanzapine: Pharmacokinetic and Pharmacodynamic Profile
Callaghan, J. T., Bergstrom, R. F., Ptak, L. R., & Beasley, C. M. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937030-00001 · Cited by 544 · cited 1×
“Since olanzapine is usually administered orally and approximately 30% of the dose enters the enterohepatic circulation [29], the gut microbiome represents a plausible mechanistic link and potential therapeutic target for olanzapine-induced metabolic dysfunction.”
BackgroundThe Genome Architecture of the Collaborative Cross Mouse Genetic Reference Population
Collaborative Cross Consortium (2012) · Genetics · doi:10.1534/genetics.111.132639 · Cited by 480
High-Resolution Genetic Mapping Using the Mouse Diversity Outbred Population
Svenson, K. L., Gatti, D. M., Valdar, W., Welsh, C. E., Cheng, R., Chesler, E. J., Palmer, A. A., McMillan, L., & Churchill, G. A. (2012) · Genetics · doi:10.1534/genetics.111.132597 · Cited by 464 · cited 1×
“This indicates that susceptibility to weight gain has a genetic component amenable to dissection via the Collaborative Cross or its sister resource, the Diversity Outbred stock [47].”
BackgroundStructural modulation of gut microbiota in life-long calorie-restricted mice
Zhang, C., Li, S., Yang, L., Huang, P., Li, W., Wang, S., Zhao, G., Zhang, M., Pang, X., Yan, Z., et al. (2013) · Nature Communications · doi:10.1038/ncomms3163 · Cited by 461 · cited 1×
“Recent studies in animal models and humans have demonstrated a causal role for the gut microbiome in obesity [19–24], which is mediated by complex interactions with host environment [25, 26], diet [21, 27] and genetics [25, 28].”
BackgroundMeta-analyses of studies of the human microbiota
Lozupone, C. A., Stombaugh, J., Gonzalez, A., Ackermann, G., Wendel, D., Vázquez-Baeza, Y., Jansson, J. K., Gordon, J. I., & Knight, R. (2013) · Genome Research · doi:10.1101/gr.151803.112 · Cited by 424 · cited 2×
“However, we note that the composition of gut bacterial communities is an imperfect proxy for their metabolic capacity [50]; further studies will be required to elucidate functional consequences of olanzapine treatment.”
BackgroundEvaluation of 16S rDNA-Based Community Profiling for Human Microbiome Research
Jumpstart Consortium Human Microbiome Project Data Generation Working Group (2012) · PLoS ONE · doi:10.1371/journal.pone.0039315 · Cited by 297
Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
Foley, D. L., & Morley, K. I. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2 · Cited by 287 · cited 2×
“However, atypical antipsychotics can induce dramatic weight gain: 11–17 kg in a systematic review of treatment-naïve adults [3] and 7–9 kg in adolescents over short-term treatment [4].”
BackgroundDavey, K. J., O’Mahony, S. M., Schellekens, H., O’Sullivan, O., Bienenstock, J., Cotter, P. D., Dinan, T. G., & Cryan, J. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2555-2 · Cited by 275
McCafferty, J., Mühlbauer, M., Gharaibeh, R. Z., Arthur, J. C., Perez-Chanona, E., Sha, W., Jobin, C., & Fodor, A. A. (2013) · The ISME Journal · doi:10.1038/ismej.2013.106 · Cited by 259 · cited 2×
“The large bloom in Verrucomicrobiae in three cages at the fourth fecal-sampling time point (S6 Figure) may be an example and is consistent with observations that the microbiota of co-housed mice tend to converge over time [25, 49].”
BackgroundResultChesler, E. J., Miller, D. R., Branstetter, L. R., Galloway, L. D., Jackson, B. L., Philip, V. M., Voy, B. H., Culiat, C. T., Threadgill, D. W., Williams, R. W., et al. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9135-8 · Cited by 257 · cited 3×
“Weight gain was initially measured in the eight inbred mouse strains that are the founders of the Collaborative Cross [44, 46].”
BackgroundDavey, K. J., Cotter, P. D., O'Sullivan, O., Crispie, F., Dinan, T. G., Cryan, J. F., & O'Mahony, S. M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.83 · Cited by 236
Zhang, Z.-J., Yao, Z.-J., Liu, W., Fang, Q., & Reynolds, G. P. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.1.58 · Cited by 230
Host genetic and environmental effects on mouse intestinal microbiota
Campbell, J. H., Foster, C. M., Vishnivetskaya, T., Campbell, A. G., Yang, Z. K., Wymore, A., Palumbo, A. V., Chesler, E. J., & Podar, M. (2012) · The ISME Journal · doi:10.1038/ismej.2012.54 · Cited by 216 · cited 2×
“The large bloom in Verrucomicrobiae in three cages at the fourth fecal-sampling time point (S6 Figure) may be an example and is consistent with observations that the microbiota of co-housed mice tend to converge over time [25, 49].”
BackgroundResultCapasso, R. M., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & St. Sauver, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.005 · Cited by 199
Teff, K. L., Rickels, M. R., Grudziak, J., Fuller, C., Nguyen, H.-L., & Rickels, K. (2013) · Diabetes · doi:10.2337/db13-0430 · Cited by 195
Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review
Leslie, W. S., Hankey, C. R., & Lean, M. E. J. (2007) · QJM · doi:10.1093/qjmed/hcm044 · Cited by 173 · cited 1×
“Furthermore, there is no reason to believe that olanzapine is unique in this respect: weight gain is a common adverse effect of numerous drugs [58], many of An Antipsychotic Drug Interacts with Gut Microbiome”
BackgroundPerry, P. J., Lund, B. C., Sanger, T., & Beasley, C. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00004 · Cited by 141 · cited 2×
“5, 25, 50, 100 mg/kg), since it produced steady-state plasma levels (21¡5 ng/ml) closest to the clinically relevant range (10–50 ng/mL; see S2 Figure and [32]).”
BackgroundAlbaugh, V. L., Judson, J. G., She, P., Lang, C. H., Maresca, K. P., Joyal, J. L., & Lynch, C. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.33 · Cited by 114
Nixon, J. P., Zhang, M., Wang, C., Kuskowski, M. A., Novak, C. M., Levine, J. A., Billington, C. J., & Kotz, C. M. (2010) · Obesity · doi:10.1038/oby.2009.471 · Cited by 114 · cited 1×
“01 g) was measured in un-anaesthetized mice using a quantitative magnetic resonance body composition analyzer [35] (EchoMRI, Houston, TX, USA).”
MethodComparative Effectiveness of Antipsychotic Drugs
Lieberman, J. A. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1069 · Cited by 88 · cited 1×
“Since their introduction in the 1990s, olanzapine and other atypical antipsychotics have come into widespread clinical use because they are efficacious and usually lack the extrapyramidal adverse drug reactions associated with older, ‘‘typical’’ antipsychotics like haloperidol [1, 2].”
BackgroundZhang, G., Terry, A. V., & Bartlett, M. G. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.08.007 · Cited by 85 · cited 1×
“[33].”
Minet-Ringuet, J., Even, P. C., Goubern, M., Tomé, D., & de Beaurepaire, R. (2006) · Appetite · doi:10.1016/j.appet.2006.01.008 · Cited by 71
The gastrointestinal microbiome: a malleable, third genome of mammals
Carroll, I. M., Threadgill, D. W., & Threadgill, D. S. (2009) · Mammalian Genome · doi:10.1007/s00335-009-9204-7 · Cited by 66 · cited 1×
“Millions of years of coevolution have shaped the metabolic capacity of the gut microbiome and its human host [18].”
BackgroundWeight gain and new onset diabetes associated with olanzapine and risperidone
Farwell, W. R., Stump, T. E., Wang, J., Tafesse, E., L'Italien, G. J., & Tierney, W. M. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.40126.x · Cited by 64 · cited 1×
“Olanzapine in particular is associated with a deterioration of metabolic parameters and development of a syndrome resembling type 2 diabetes [3–6].”
BackgroundThorsing, M., Klitgaard, J. K., Atilano, M. L., Skov, M. N., Kolmos, H. J., Filipe, S. R., & Kallipolitis, B. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064518 · Cited by 57 · cited 1×
“Indeed, other antipsychotic drugs and their metabolites have antimicrobial activity in vitro: for instance, chlorpromazine against Mycobacterium tuberculosis [55] and thioridazine against a methicillin-resistant Staphylococcus aureus isolate [56].”
BackgroundSimon, G. M., Cheng, J., & Gordon, J. I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208669109 · Cited by 55 · cited 1×
“After 7 weeks of treatment, mice were moved to conventional housing (maintaining the same cage assignments) at which time each mouse was gavaged with 200 caecal slurry (500 uL caecal contents form a single conventionally-raised C57BL/6J female diluted 1:10 in sterile PBS)[34].”
MethodNo mental health without physical health.
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60211-0 · Cited by 44 · cited 1×
“Understanding the mechanisms [10– 13] of these adverse drug reactions and developing mitigating strategies are of considerable clinical importance [14].”
BackgroundKristiansen, J. E. H. (1979) · Acta Pathologica Microbiologica Scandinavica Section B Microbiology · doi:10.1111/j.1699-0463.1979.tb02445.x · Cited by 43 · cited 1×
“Indeed, other antipsychotic drugs and their metabolites have antimicrobial activity in vitro: for instance, chlorpromazine against Mycobacterium tuberculosis [55] and thioridazine against a methicillin-resistant Staphylococcus aureus isolate [56].”
BackgroundDetermination of Olanzapine in a Postmortem Case
Jenkins, A. J., Sarconi, K. M., & Raaf, H. N. (1998) · Journal of Analytical Toxicology · doi:10.1093/jat/22.7.605 · Cited by 41 · cited 1×
“Olanzapine undergoes enterohepatic recycling, and an autopsy report found that olanzapine was concentrated by one to two orders of magnitude in bile relative to the blood [54].”
BackgroundWang, C., Zhang, Z., Sun, J. Y., Zhang, X., Mou, X., Zhang, X.-R., Shang, X., & Zhang, T.-Q. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.014 · Cited by 33 · cited 1×
“Olanzapine in particular is associated with a deterioration of metabolic parameters and development of a syndrome resembling type 2 diabetes [3–6].”
BackgroundComparative Effectiveness of Antipsychotic Drugs
Gupta, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.591 · Cited by 20
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Extensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905
“This raises the possibility that direct bacterial inhibition may not only manifest as side effect for antipsychotics 26, but also be part of their MoA.”
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration
Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Physiology · doi:10.1113/jp273106 · Cited by 813
“Indeed, recent studies from our group (Davey et al. 2012; 2013) and others (Morgan et al. 2014; Bahr et al. 2015) point to a key role of the microbiome in manifesting antipsychotic-induced weight gain.”
BackgroundSystematic Review of Gut Microbiota and Major Depression
Cheung, S. G., Goldenthal, A. R., Uhlemann, A.-C., Mann, J. J., Miller, J. M., & Sublette, M. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00034 · Cited by 597
Metadata
- Authors
- Morgan, A. P., Crowley, J. J., Nonneman, R. J., Quackenbush, C. R., Miller, C. N., Ryan, A. K., Bogue, M. A., Paredes, S. H., Yourstone, S., Carroll, I. M., Kawula, T. H., Bower, M. A., Sartor, R. B., & Sullivan, P. F.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Jackson Laboratory (US)
- Corresponding author
- Sullivan, Patrick F.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-15
- Volume
- 9
- Issue
- 12
- Pages
- e115225
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4266663
- OpenAlex
- W2072944905
- Cited by
- 197
- References
- 61
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 19 · 2023: 25 · 2022: 21 · 2021: 17 · 2020: 22 · 2019: 23 · 2018: 16 · 2017: 9 · 2016: 7 · 2015: 6
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- UNC Libraries
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (P40OD010995)
- National Institute of Mental Health (R21MH097173, K01MH094406, F30MH103925)
- National Institute of General Medical Sciences (T32GM008719, T32GM067553)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034987, P30DK056350)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- olanzapine, gut microbiota, weight gain, antipsychotic adverse effects, germ-free mice, antimicrobial activity, atypical antipsychotics, drug-microbiome interactions
- MeSH terms
- Gastrointestinal Microbiome, Olanzapine, Animals, Benzodiazepines, Female, Antipsychotic Agents, Weight Gain, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.